NASDAQ : ENLV

Enlivex Therapeutics Ltd. — Earnings Estimates

$2.09 USD

$0.14 (7.18%)

Volume
338.61K
Average Volume
114.57K
Market Capitalization
$35.18M
P/E Ratio
0.01
Dividend Yield
0.00%
Price Target
$15.00
Year High
$31.50
Year Low
$1.80
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$193.24

Annual earnings financials

ENLV financial data with annual/quarterly toggle

ENLV GAAP EPS - Annual & Quarterly

ENLV Sales Revenue - Annual & Quarterly

ENLV Shares Outstanding - Annual & Quarterly

Hover over bars to see exact values. Data includes up to 12 years of annual financials and up to 20 quarters of quarterly data from FMP Financial Data.

ENLV Estimated and Actual Revenue by Quarter
ENLV Estimated and Actual EPS by Quarter
ENLV Analyst Forecasts — EBITDA & EBIT
Quarter Date No of Estimates Ebitda Ebit
Low High Average Low High Average
2028-12-31 0 - - - - - -
2028-09-30 0 - - - - - -
2028-06-30 0 - - - - - -
2028-03-31 0 - - - - - -
2027-12-31 0 - - - - - -
2027-09-30 0 - - - - - -
ENLV Analyst Forecasts — Net Income & SGA Expense
Quarter Date No of Estimates NetIncome SgaExpense
Low High Average Low High Average
2028-12-31 0 -12.54M -12.54M -12.54M - - -
2028-09-30 0 -11.31M -11.31M -11.31M - - -
2028-06-30 0 -10.51M -10.51M -10.51M - - -
2028-03-31 0 -11.08M -11.08M -11.08M - - -
2027-12-31 0 -963.97K -963.97K -963.97K - - -
2027-09-30 0 -963.97K -963.97K -963.97K - - -
ENLV Analyst Forecasts — Revenue & EPS
Quarter Date No of Revenue Estimates Revenue No of EPS Estimates EPS
Low High Average Low High Average
2028-12-31 0 - - - 1 -3.903 -3.903 -3.903
2028-09-30 0 - - - 1 -3.519 -3.519 -3.519
2028-06-30 0 - - - 1 -3.27 -3.27 -3.27
2028-03-31 0 - - - 1 -3.447 -3.447 -3.447
2027-12-31 0 - - - 1 -0.3 -0.3 -0.3
2027-09-30 0 - - - 1 -0.3 -0.3 -0.3